Related references
Note: Only part of the references are listed.RIP2 enhances cell survival by activation of NF-κB in triple negative breast cancer cells
Rola Jaafar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
Ricardo L. B. Costa et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
Ling Wang et al.
CANCER CELL INTERNATIONAL (2018)
CD146 mediates an E-cadherin-to-N-cadherin switch during TGF-β signaling-induced epithelial-mesenchymal transition
Yanbin Ma et al.
CANCER LETTERS (2018)
ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
Xiang Zhang et al.
CELL DEATH & DISEASE (2018)
Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression
Hao-Yu Lin et al.
ONCOGENESIS (2018)
MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines
Yuan-Ke Liang et al.
NPJ BREAST CANCER (2018)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Nestin and cluster of differentiation 146 expression in breast cancer: Predicting early recurrence by targeting metastasis?
Ekaterini Christina Tampaki et al.
TUMOR BIOLOGY (2017)
Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α
Xiao-Wei Dou et al.
THERANOSTICS (2017)
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
Omar Elaskalani et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
Katharina Gohr et al.
BMC CANCER (2017)
Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance
Kunnathur Murugesan Sakthivel et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway
Satyendra C. Tripathi et al.
CANCER RESEARCH (2017)
CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells
D. Maciaczyk et al.
BRITISH JOURNAL OF CANCER (2017)
MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation
Yuan-Ke Liang et al.
CANCER LETTERS (2017)
Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification
Fouzia Guestini et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
New Insights into the Epithelial-to-Mesenchymal Transition in Cancer
Xiaolong Qi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy
Baek Kim et al.
BMC CANCER (2015)
The multifaceted role of CD146/MCAM in the promotion of melanoma progression
Xing Lei et al.
CANCER CELL INTERNATIONAL (2015)
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Rishil J. Kathawala et al.
DRUG RESISTANCE UPDATES (2015)
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
Steven J. Isakoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner
Shan Shao et al.
MOLECULAR CANCER (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway
T. Namba et al.
CELL DEATH & DISEASE (2015)
Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role
Xiaojin Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
The fate of chemoresistance in triple negative breast cancer (TNBC)
Elma A. O'Reilly et al.
BBA CLINICAL (2015)
Breast cancer stem cells, EMT and therapeutic targets
Srishti Kotiyal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance
Mafalda Videira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
Eun Young Park et al.
CANCER RESEARCH (2014)
Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer
Suganthi Chittaranjan et al.
CLINICAL CANCER RESEARCH (2014)
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gunter von Minckwitz et al.
LANCET ONCOLOGY (2014)
KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer
Stina M. Singel et al.
NEOPLASIA (2014)
Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance
Cletus A. Pinto et al.
CANCER LETTERS (2013)
Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line
Jin Ren et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma
Shangwen Liu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Epithelial-mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
Chiara Foroni et al.
CANCER TREATMENT REVIEWS (2012)
P53 and its molecular basis to chemoresistance in breast cancer
Stian Knappskog et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer
Qiqun Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Notch Signaling Activated by Replication Stress-Induced Expression of Midkine Drives Epithelial-Mesenchymal Transition and Chemoresistance in Pancreatic Cancer
Cenap Guengoer et al.
CANCER RESEARCH (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Breast cancer chemoresistance: Emerging importance of cancer stem cells
Suebwong Chuthapisith et al.
SURGICAL ONCOLOGY-OXFORD (2010)
Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
Chelsea C. Pinnix et al.
CANCER RESEARCH (2009)
Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
Nawneet K. Kurrey et al.
STEM CELLS (2009)
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines
Gwladys Zabouo et al.
BREAST CANCER RESEARCH (2009)
Share Paper
